Use of recombinant human bone morphogenetic protein-2 in spine surgery
Marios Lykissas, Department of Spine Surgery, Metropolitan Hospital, 18547 Athens, Greece
Ioannis Gkiatas, Orthopaedic Department, University Hospital of Ioannina, 45500 Ioannina, Greece
Author contributions: Lykissas M performed the majority of the writing, collecting all the bibliography that was used; Gkiatas I performed writing as well as input in writing the paper and designed the outline.
Conflict-of-interest statement: There is no conflict of interest.
Open-Access: This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Correspondence to: Marios Lykissas, MD, Department of Spine Surgery, Metropolitan Hospital, Ethnarxou Makariou 9 & El. Venizelou 1, 18547 Athens, Greece. email@example.com
Telephone: +30-694-4591915 Fax: +30-210-4814887
Received: December 18, 2016
Peer-review started: December 20, 2016
First decision: January 28, 2017
Revised: February 5, 2017
Accepted: April 18, 2017
Article in press: April 20, 2017
Published online: July 18, 2017